Monthly Archives: March 2021

Brazil’s Minister of Health works to purchase more COVID Vaccine doses

By on .

By Daniel R. Lucey MD, MPH, FIDSA On Thursday (March 4) a release on the PAHO COIVD-19 website stated: “The Brazil Ministry of Health announced the purchase of new COVID-19 vaccines; 138 million doses are expected to be incorporated in the National Immunization Program starting May 2021.” The day before (on March 3) the Brazil Ministry of Health […]

Ghana kicks off Africa’s COVID-19 vaccine rollout

By on .

by Bertha Serwa Ayi, M.D., FACP, FIDSA, MBA With eyes tightly shut in anticipation of his injection, Dr. Frederick Kwarteng, Head of Department of the Orthopedics, Accident and Emergency at the Korlebu Teaching Hospital in Accra, Ghana became one of the first medical doctors in Africa to receive the first dose of COVISHIELD. Ghana became […]

Will survivors of variant P.1 have antibodies that also neutralize B.1.351 — and vice versa?

By on .

By Daniel R. Lucey MD, MPH, FIDSA The SARS-CoV-2 variants first described in Manaus, Brazil “P.1.” and in South Africa “B.1.351” share at least five mutations including the antibody-evading changes at amino acids 484 and 417 in the spike protein. Potential cross-protection against the P.1 variant by the new Moderna-NIH B1.351 variant vaccine has been […]

The new Moderna/NIH B.1.351-specific vaccine study should add the P.1 variant

By on .

By Daniel R. Lucey MD, MPH, FIDSA Two manuscripts from Brazil, newly posted by accomplished researchers on preprint servers, report that the P.1 variant “associated with rapid transmission in Manaus” (by Faria N.  et al.) and reported in the U.S. and 28 other nations, “may escape from neutralizing antibodies generated in response to polyclonal stimulation […]